Abbott Says Agreement Reached To Reopen Baby Formula Plant
Newsy
Abbott came under scrutiny after the FDA began investigating four bacterial infections among infants who consumed the plant's powdered formula.
Baby formula maker Abbott said Monday it has reached an agreement with U.S. health regulators to restart production at its largest domestic factory, though it will be well over a month before any new products ship from the site to help alleviate the national shortage facing parents.
Abbott did not immediately detail the terms of the agreement with the Food and Drug Administration, which has been investigating safety concerns at the Sturgis, Michigan, plant since early this year. The consent decree amounts to a legally binding agreement between the FDA and the company on steps needed to reopen the factory.
An FDA spokeswoman did not immediately respond to a request for comment on the announcement Monday evening.
